Cell biologists at Jefferson Medical College and the Kimmel Cancer Center of Thomas Jefferson University in Philadelphia have found that the protein fragment endorepellin blocks both skin and lung cancer tumors from progressing in animal models by preventing their ability to recruit new blood vessels, a process called angiogenesis. They showed that endorepellin has surprisingly powerful effects on halting a cancer tumor's ability to move about and spread.
The researchers believe that these latest findings, appearing November 15, 2006 in the Journal of the National Cancer Institute, could lead to a new type of tumor inhibitor that might be used to prevent cancer from spreading to other areas in the body.
The researchers, led by Renato Iozzo, M.D., professor of pathology, anatomy and cell biology at Jefferson Medical College of Thomas Jefferson University, used two animal models of cancer to study squamous cell carcinoma and lung carcinoma. When they injected animals with artificially created "recombinant" endorepellin, they discovered that it blocked tumor growth, metabolism and angiogenesis. They also found for the first time that endorepellin targets the tumor endothelial cells, blocking the creation of new blood vessels.
"These findings have major implications for cancer treatments for a range of solid tumors such as lung, prostate and breast," Dr. Iozzo says. "All of these tumors depend on angiogenesis, so we think this could be an effective adjuvant therapy for cancer."
Endorepellin is part of the protein perlecan, which plays fundamental roles in vascular biology as scaffolding for blood vessel formation in development. In cancer, perlecan not only regulates growth factor activity, but also is a barrier to invading cancer cells.
Anti-angiogenesis drugs were all the rage in the late 1990s, when animal studies showed two drugs seemingly "melting" tumors in mice. But disappointing human clinical trials since then have scaled back expectations, and most now see such drugs as part of a treatment milieu that includes surgery, chemotherapy and radiation. More recent study results, however, Dr. Iozzo says, have renewed interest in the drugs' potential.
Dr. Iozzo says that these results suggest that endorepellin might be used to help prevent metastatic cancer spread in patients who have had a primary tumor removed. "It could be used preventatively and for maintenance, and in combination with other drugs," he notes.
"While endorepellin prevents the formation of the original blood vessels in tumor development, I think it would be more effectively used after the tumor has formed and cells try to migrate and spread," Dr. Iozzo says. The researchers are hoping to begin clinical testing of endorepellin in the near future.
Steve Benowitz | EurekAlert!
Novel mechanisms of action discovered for the skin cancer medication Imiquimod
21.10.2016 | Technische Universität München
Second research flight into zero gravity
21.10.2016 | Universität Zürich
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
21.10.2016 | Health and Medicine
21.10.2016 | Information Technology
21.10.2016 | Materials Sciences